The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Cardiology

• Publication date

  2007-06-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2007.03.029PMID 17599421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

  2007cited by this paper
• Statin therapy in the treatment of Alzheimer disease: what is the rationale?

  2005cited by this paper
• Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

  2005cited by this paper
• Underrecognition of Cognitive Impairment in Assisted Living Facilities

  2005cited by this paper
• Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study.

  2004cited by this paper
• Applied Longitudinal Analysis

  2004cited by this paper
• The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Type 2 diabetes mellitus and cognition: an understudied issue in women's health.

  2003cited by this paper
• Double placebo design in a prevention trial for Alzheimer's disease.

  2002cited by this paper
• The PHQ-9: validity of a brief depression severity measure.

  2001cited by this paper
• Studies of Interference in Serial Verbal Reactions

  2001cited by this paper
• Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches

  2001cited by this paper
• The continuing epidemics of obesity and diabetes in the United States.

  2001influential reference
• CASCADE: A European Collaborative Study on Vascular Determinants of Brain Lesions

  2000cited by this paper
• Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Prognosis with stroke in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

  2000cited by this paper
• Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

  2000cited by this paper
• The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

  1999cited by this paper
• The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons

  1999cited by this paper
• Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

  1999cited by this paper
• The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.

  1998cited by this paper
• Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

  1998cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998cited by this paper
• Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study.

  1998cited by this paper
• Risk of dementia among persons with diabetes mellitus: a population-based cohort study.

  1997cited by this paper
• Is Type II Diabetes Associated With an Increased Risk of Cognitive Dysfunction?: A critical review of published studies

  1997cited by this paper
• NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study

  1997cited by this paper
• Risk of dementia: The Rotterdam Study

  1997cited by this paper
• Neuropsychological assessment, 3rd ed.

  1995cited by this paper
• Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men

  1995cited by this paper
• Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients

  1994cited by this paper
• Stroop interference: aging effects assessed with the Stroop Color-Word Test.

  1993cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• [Magnetic resonance imaging of the brain].

  1988cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Beta cells to brain cells: The pivotal role of insulin and glucose metabolism in Alzheimer's disease

  2025cites this paper
• Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by Age.

  2025cites this paper
• Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial

  2024cites this paper
• Association between glycemic status and all-cause mortality among individuals with dementia: a nationwide cohort study

  2024cites this paper
• Association of systolic blood pressure variability with cognitive decline in type 2 diabetes: A post hoc analysis of a randomized clinical trial

  2024cites this paper
• Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial

  2024cites this paper
• Blood Pressure and Cognitive Function in Older Adults.

  2024cites this paper
• Type 2 diabetes mellitus and cognitive function: understanding the connections

  2022cites this paper
• Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes

  2022cites this paper
• Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment

  2022cites this paper
• Blood Pressure and Vascular Cognitive Impairment

  2022cites this paper
• Cognitive disorder and dementia in type 2 diabetes mellitus

  2022cites this paper
• Racial/Ethnic Variation in White Matter Hyperintensity Progression in the ACCORDION MIND Study

  2022cites this paper
• Influence of Baseline Diastolic Blood Pressure on the Effects of Systolic Blood Pressure Lowering on Cognitive Function in Type 2 Diabetes Mellitus.

  2022cites this paper
• The Role of Renin Angiotensin Aldosterone System in the Progression of Cognitive Dysfunction in Chronic Kidney Disease Patients with Alzheimer’s Disease

  2021cites this paper
• Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome‐Wide Interaction Meta‐Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies

  2021cites this paper
• Correlates of deep brain stimulation consensus conference decision to treat primary dystonia.

  2021cites this paper
• Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia.

  2021cites this paper
• Cognitive dysfunctions in individuals with diabetes mellitus

  2019cites this paper
• Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset

  2019cites this paper
• Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics

  2019cites this paper
• Nonesterified fatty acids, cognitive decline, and dementia.

  2019cites this paper
• Glucose regulation and face recognition deficits in older adults: the role of attention

  2018cites this paper
• Évaluation comparative par la technique d’IRM de perfusion de l’atteinte microcirculatoire cardiaque du patient diabétique en fonction de l’existence d’une coronaropathie ou d’une atteinte microcirculatoire périphérique

  2018cites this paper
• Abnormality Segmentation and Detection in Brain Images using Artificial Neural Networks

  2018cites this paper
• Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes

  2018cites this paper
• An insight into the brain of patients with type-2 diabetes mellitus and impaired glucose tolerance using multi-modal magnetic resonance image processing

  2018cites this paper
• Treatment of vascular cognitive impairment

  2017cites this paper
• Glucose targets for preventing diabetic kidney disease and its progression.

  2017cites this paper
• Cognitive Performance Does not Limit Physical Activity Participation in the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P).

  2017cites this paper
• A Paleolithic Diet with and without Combined Aerobic and Resistance Exercise Increases Functional Brain Responses and Hippocampal Volume in Subjects with Type 2 Diabetes

  2017cites this paper
• The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD‐MIND Study

  2017cites this paper
• Investigation of glucose fluctuations by approaches of multi-scale analysis

  2017cites this paper
• Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.

  2017cites this paper
• Neurocognitive impairment in patients with comorbid diabetes mellitus and depression

  2017cites this paper
• Robustness of Automated Methods for Brain Volume Measurements across Different MRI Field Strengths

  2016cites this paper
• ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial

  2016cites this paper
• Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study.

  2016cites this paper
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

  2015cites this paper
• Vascular Cognitive Impairment, Part 2 Cognitive impairment after acute stroke is likely under-appreciated despite its impact.

  2015cites this paper
• MEDICATION DISCREPANCIES ASSOCIATED WITH DIABETES MELLITUS IN COMMUNITY DWELLING PRIMARY CARE OLDER ADULTS

  2015cites this paper
• Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes

  2015cites this paper
• Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data.

  2014cites this paper
• Spatial Patterns of Structural Brain Changes in Type 2 Diabetic Patients and Their Longitudinal Progression With Intensive Control of Blood Glucose

  2014cites this paper
• Magnitude of Cognitive Dysfunction in Adults with Type 2 Diabetes: A Meta-analysis of Six Cognitive Domains and the Most Frequently Reported Neuropsychological Tests Within Domains

  2014cites this paper
• Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.

  2014cites this paper
• Multi-Scale Glycemic Variability: A Link to Gray Matter Atrophy and Cognitive Decline in Type 2 Diabetes

  2014cites this paper
• Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality

  2014cites this paper
• Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

  2014cites this paper
• Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

  2014cites this paper
• Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

  2014cites this paper
• Effect of Hypoglycemia on Brain Structure in People With Type 2 Diabetes: Epidemiological Analysis of the ACCORD-MIND MRI Trial

  2014cites this paper
• Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND.

  2013influential citation
• Stroke, Cognitive Deficits, and Rehabilitation: Still an Incomplete Picture

  2013cites this paper
• Addressing the Glucose Triad for Comprehensive Glycemic Control

  2013cites this paper
• Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.

  2013cites this paper
• Segmentation of Tumor In MRI Brain Images And Classification Using Neural NetworK

  2013cites this paper
• Alzheimer’s Disease and Type 2 Diabetes Mellitus: Risk Factors and Effectiveness of Antidiabetic Agents in Treatment of Alzheimer’s Disease

  2013cites this paper
• Albuminuria and cognitive decline in people with diabetes and normal renal function.

  2013cites this paper
• Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes

  2012cites this paper
• Influence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes

  2012cites this paper
• In fl uence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes Results from the Women ’ s Health Initiative Magnetic Resonance Imaging Studies

  2012cites this paper
• Baseline comparison of three health utility measures and the feeling thermometer among participants in the action to control cardiovascular risk in diabetes trial

  2012cites this paper
• Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

  2012cites this paper
• Type 2 Diabetes and Cognitive Impairment: Linking Mechanisms

  2012cites this paper
• Cognition and Hemodynamics

  2012cites this paper
• The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers.

  2012influential citation
• Dementia, Stroke, and Vascular Risk Factors; a Review

  2012cites this paper
• Late and early onset dementia: what is the role of vascular factors? A retrospective study.

  2012cites this paper
• Abnormality Segmentation in Brain Images Via Distributed Estimation

  2012cites this paper
• Cognitive function, dementia and type 2 diabetes mellitus in the elderly

  2011cites this paper
• Biomarkers of Renal Function and Cognitive Impairment in Patients With Diabetes

  2011cites this paper
• [Alzheimer's disease and vascular risk factors].

  2011cites this paper
• Association of the Metabolic Syndrome with Age-Related, Nonatherosclerotic, Chronic Medical Conditions

  2011cites this paper
• Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases

  2011cites this paper
• Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

  2011cites this paper
• Improved diabetes control in the elderly delays global cognitive decline

  2011cites this paper
• Cognitive Function and Fine Motor Speed in Older Women with Diabetes Mellitus: Results from the Women's Health Initiative Study of Cognitive Aging

  2011cites this paper
• Development and Pilot-Testing of a Brief Psychosocial Group Intervention Protocol for Type 2 Diabetes Self-Management

  2011cites this paper
• Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

  2011cites this paper
• Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications

  2011cites this paper
• Segmentation of pathology by statistical modeling and distributed estimation

  2011cites this paper
• Tratamento da demência vascular

  2011cites this paper
• Does Diabetes Mellitus Alter the Onset and Clinical Course of Vascular Dementia?

  2010cites this paper
• The metabolic syndrome--new and old data.

  2010cites this paper
• Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease

  2010cites this paper
• Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke.

  2010cites this paper
• The thiazolidinedione controversy in cardiovascular risk.

  2010cites this paper
• Targets for the Prevention of Dementia

  2010cites this paper
• Type 2 Diabetes, Related Conditions, in Relation and Dementia: An Opportunity for Prevention?

  2010cites this paper
• Progress in the development of new drugs in Alzheimer's disease

  2010cites this paper
• Type 2 diabetes and risk for functional decline and disability in older persons.

  2010cites this paper
• High normal fasting blood glucose is associated with dementia in Chinese elderly

  2010cites this paper
• The Relationship Between the Continuum of Elevated Adiposity, Hyperinsulinemia, and Type 2 Diabetes and Late-onset Alzheimer’s Disease: An Epidemiological Perspective

  2010cites this paper
• Diabetes and the Brain – An Epidemiologic Perspective

  2010cites this paper
• Blood Pressure and Cognitive Outcome

  2010cites this paper
• Diabetes, Insulin and Alzheimer's Disease

  2010cites this paper
• Diabetes, related conditions, and dementia.

  2010cites this paper
• Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study.

  2009cites this paper
• Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors

  2009cites this paper